Tissue-shrinkage Correction Factor in the Calculation of Prostate Cancer Volume
- 1 December 1996
- journal article
- Published by Wolters Kluwer Health in The American Journal of Surgical Pathology
- Vol. 20 (12), 1501-1506
- https://doi.org/10.1097/00000478-199612000-00009
Abstract
Many studies that have calculated prostate cancer volumes from microscopic slides have used correction factors, ranging from 1.22 to 1.5, to compensate for tissue shrinkage during tissue processing. We undertook a study to measure tissue shrinkage directly because our experience suggested less shrinkage than that reported by others. Ten prostatectomy specimens were processed in a uniform manner. Multiple identical linear measurements were taken at four stages of processing: in the fresh state, following fixation, following processing, and from the microscopic slide. Linear shrinkage following fixation was minimal (4.1%) but increased to 14.5% following tissue processing. With rehydration and expansion on the flotation bath, tissues swelled so that net linear tissue shrinkage was 4.3%, and net volumetric tissue shrinkage was 12.4%, which translates into a correction factor for tissue shrinkage of 1.14. The following variables had no statistically significant effect on shrinkage: concentration of formalin, whole-mount versus quadrant sections, thickness of tissue slices, length of time in the alcohol dehydration steps, and temperature of the flotation bath over a range of 35 to 45 degrees C. This study suggests that (a) tissue-shrinkage correction factors that have been used in some previous studies may not be applicable for all laboratories because of interlaboratory variations in tissue-processing procedures or differences in measuring shrinkage; and (b) some calculated tumor volumes that have been used for prognostic thresholds may be high because of inflated tissue-shrinkage correction factors.Keywords
This publication has 23 references indexed in Scilit:
- Minimal or No Cancer in Radical Prostatectomy SpecimensThe American Journal of Surgical Pathology, 1995
- Staging of prostate cancer with endorectal MR imaging: lessons from a learning curve.RadioGraphics, 1995
- The Volume of Prostate Cancer in the Biopsy Specimen Cannot Reliably Predict the Quantity of Cancer in the Radical Prostatectomy Specimen on an Individual BasisJournal of Urology, 1995
- Standardized in vitro mapping with multiple core biopsies of total prostatectomy specimens: localization and prediction of tumour volume and gradeBritish Journal of Urology, 1994
- Combining Prostate Specific Antigen with Cancer and Gland Volume to Predict More Reliably Pathological Stage: The Influence of Prostate Specific Antigen Cancer DensityJournal of Urology, 1994
- Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancerPublished by American Medical Association (AMA) ,1994
- Staging of early prostate cancer: A proposed tumor volume-based prognostic indexUrology, 1993
- The Distribution of Residual Cancer in Radical Prostatectomy Specimens in Stage a Prostate CancerJournal of Urology, 1991
- Evaluation of Transrectal Ultrasound in the Early Detection of Prostate CancerJournal of Urology, 1989
- Tumor Volume Versus Percentage of Specimen Involved by Tumor Correlated with Progression in Stage a Prostatic CancerJournal of Urology, 1988